As of June 13, 2025, Quantrx Biomedical Corp (QTXB) reports a ROA (Return on Assets) of -4370.42%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Quantrx Biomedical Corp's ROA (Return on Assets)
Over recent years, Quantrx Biomedical Corp's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2021-12-31 | -4370.42% |
| 2020-12-31 | -455.94% |
| 2019-12-31 | -452.80% |
| 2018-12-31 | -126.65% |
| 2017-12-31 | 62.49% |
This slight downward trend highlights how Quantrx Biomedical Corp manages its efficiency in using assets to generate earnings over time.
Comparing Quantrx Biomedical Corp's ROA (Return on Assets) to Peers
To better understand Quantrx Biomedical Corp's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Quantrx Biomedical Corp (QTXB) | -4370.42% |
| PAVmed Inc (PAVM) | 129.78% |
| United American Healthcare Corp (UAHC) | 3.39% |
| Remedent Inc (REMI) | -11.43% |
| DiaSys Corp (DYXC) | -31.55% |
| Paradigm Medical Industries Inc (PDMI) | -36.82% |
Compared to its competitors, Quantrx Biomedical Corp's ROA (Return on Assets) is lower than all peers, suggesting potential inefficiency in asset utilization.